Better health monitoring can cut adverse drug reactions, say researchers
Better health monitoring could cut the number of adverse drug reactions and guide development of safer formulations say researchers.
Archives for September 23, 2015
Intertek opens bioanalysis plant in UK to support biosimilar growth
Intertek has added 10,000 ft² of bioanalytical laboratory space through a new UK facility, the second to be opened this year.
Cobra and Manchester Uni receive grant for biologics scale-up
Cobra Biologics, a Swedish contract development and manufacturing organisation, has launched a project to improve scale-up of biologics with the University of Manchester, UK.
Ashland to spin specialty chemicals business into standalone company
It will be business as usual for pharma customers as Ashland approves a plan to separate into two independent companies, the ingredients firm says.
Regulators and patients driving demand for Phase IV studies, says Quintiles
Full spectrum CROs are well-positioned to service the growing demand for late-stage observational trials driven by regulatory and patient pressure, says Quintiles.